Dr. Tejinder Kataria

Dr. Tejinder Kataria, a radiation oncologist with international renown, has unveiled the first Infinity Linear Accelerator with Volumetric Modulated Arc Therapy (VMAT) in India. Additionally, she started the use of stereotactic body radiotherapy and unveiled the first integrated brachytherapy unit in North India. Dr. Kataria, who has more than 35 years of experience, is credited with founding the Radiation Oncology Department at the Rajiv Gandhi Cancer Institute in New Delhi, the Artemis Health Institute in Gurugram, and the Radiation Oncology Division at Medanta-Gurugram. Dr. Tejinder Kataria completed her education at esteemed institutions in India and abroad, such as Harvard University, PGI Chandigarh, the University of Cambridge, and the University of Leeds. The most recent developments in radiation therapy, including stereotactic radiosurgery (SRS), image-guided radiotherapy (IGRT), intensity-modulated radiotherapy (IMRT), image-guided brachytherapy, total skin electron therapy (TSET), and total body irradiation, have been introduced by her at Medanta (TBI). Since 2005, Dr. Kataria has worked together with the QUATRO Asia team of the International Atomic Energy Agency, which is based in Vienna. She has also participated in the 11th year of the National Cancer Control Program Task Force Committee for the Ministry of Health and Family Welfare in New Delhi. In October 2009, After joining the Medanta Cancer Institute, Dr. Kataria played a key role in establishing the Division of Radiation Oncology. With the help of a committed team of professionals and cutting-edge equipment, this division offers comprehensive cancer care. This section houses the first Infinity Linear Accelerator with VMAT, Synergy-S with Beam Modulator, and SRS facilities in India. Additionally, Nucletron's integrated brachytherapy unit is the first of its kind in northern India and is capable of administering both high dose rate brachytherapy and low dose rate seed implants. The most recent methods of stereotactic radiation, such as micro multi-leaf collimation, whole-body stereotactic radiotherapy (SBRT), image-guided radiotherapy (IGRT), intensity-modulated radiotherapy (IMRT), and 3-D conformal radiation, have also been implemented thanks in large part to Dr. Kataria (3D CRT). For treatment planning, the division makes use of PET-CT, MRI, SPECT, DSA, and CT-simulator fusion. The Rajiv Gandhi Cancer Institute and the Department of Radiation Oncology at Artemis Health Institute, both of which opened their doors in 2007, were both founded by Dr. Kataria prior to her time at Medanta.